Phase I trial of gentamicin formulations (LJPC-30Sa and LJPC-30Sb)

Trial Profile

Phase I trial of gentamicin formulations (LJPC-30Sa and LJPC-30Sb)

Phase of Trial: Phase I

Latest Information Update: 11 May 2015

At a glance

  • Drugs Gentamicin (Primary)
  • Indications Bacterial infections; Cystic fibrosis-associated respiratory tract infections; Duchenne muscular dystrophy
  • Focus Adverse reactions
  • Sponsors La Jolla Pharmaceutical Company
  • Most Recent Events

    • 11 May 2015 New trial record
    • 07 May 2015 Following a pre-Investigational New Drug application meeting with the US FDA, La Jolla has received guidance that it may proceed with this proposed Phase I clinical trial following the submission of an IND, according to a media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top